PAI Pharma acquires Nivagen Pharmaceuticals

PAI Pharma agreed to acquire Nivagen Pharmaceuticals. Reported deal value: Undisclosed. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Sacramento, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.

PAI Pharma , a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines, today announced the acquisition of Nivagen Pharma ceuticals , Inc. , a California -based pharmaceutical company with advanced aseptic manufacturing infrastructure and a robust pipeline of ready -to-use sterile injectable s